CERE — Cerevel Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00Cerevel rises after Wells Fargo starts with 'overweight'
U.S. RESEARCH ROUNDUP-Activision Blizzard, Inari Medical, Rent the Runway
Brief: Cerevel Therapeutics announces pricing of $254 million public offering of common stock and concurrent $300 million private offering of convertible senior notes
U.S. STOCKS ON THE MOVE-Warby Parker, NV5 Global, Absci
U.S. STOCKS ON THE MOVE-Cyclacel, Major U.S. banks, Gold miners
Cerevel Therapeutics slides on stock, convertible debt deals
Brief: Cerevel Therapeutics Announces Proposed Private Offering Of Convertible Senior Notes
Brief: Cerevel Therapeutics Announces Proposed Public Offering Of Common Stock
Brief: Cerevel Therapeutics Holdings Inc - Offering $250 Million Of Shares Of Our Common Stock - SEC Filing
U.S. STOCKS ON THE MOVE-Scynexis, Sierra Wireless, CymaBay
U.S. STOCKS ON THE MOVE-PerkinElmer, Tesla, Scisparc
Cerevel rises on starting mid-stage trials of schizophrenia therapy
Brief: Cerevel Therapeutics Reports Second Quarter 2022 Financial Results
U.S. RESEARCH ROUNDUP-Bank Ozk, Bunge, Littelfuse
Brief: Cerevel Therapeutics Appoints Suneet Varma To Board Of Directors
U.S. RESEARCH ROUNDUP- Appfolio, Hyatt Hotels, TransDigm Group
Brief: Cerevel Therapeutics Files Prospectus Covers Offer And Resale, From Time To Time, By Selling Stockholders Of Up To 76.8 Million Shares Of Common Stock
Brief: Cerevel Therapeutics Reports First Quarter 2022 Financial Results And Business Updates
Berenberg starts Cerevel with "buy" on pipeline potential